Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Boreals Peptides presents Retatrutide Synedica 40mg pen pharmaceutical-grade research peptide available across all Canadian provinces
"'Bah, humbug
Emerging research suggests GLP-1 receptor agonists may reduce inflammatory markers such as C-reactive protein and pro-inflammatory cytokines, though dedicated clinical trials examining low-dose regimens specifically for inflammation are lacking
At the same time, your neurologist can evaluate how GLP-1 therapy might fit into your MS care
doi: 10.3390/ijms22179459 107 ZulloAHassanCCristofariFAndrianiADe FrancescoVIerardiEet al
US$ 22.12
US$ 25.07
US$ 28.78
